SCHEMBL17640413

SCHEMBL17640413

CCN1c2ccccc2N(c2ccc(-n3nc(-c4ccccc4)nc3-c3ccccc3)cc2)c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NR1H3 Q13133 5/20 0.47
▸ NR1H2 P55055 2/20 0.47
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ ADORA1 P30542 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17640398 0.99 NR1H3 (0.49) NR1H3NR1H2NPC1RAB9AADORA1
SCHEMBL17640385 0.99 NR1H3 (0.49) NR1H3NR1H2NPC1RAB9AADORA1
SCHEMBL17640505 0.97 NR1H3 (0.48) NR1H3NR1H2NPC1RAB9ASMN1; SMN2
SCHEMBL17640396 0.97 NR1H3 (0.48) NR1H3NR1H2NPC1RAB9ASMN1; SMN2
SCHEMBL17640516 0.96 NR1H3 (0.46) NR1H3NR1H2NPC1RAB9ASMN1; SMN2
SCHEMBL19499722 0.96 NR1H3 (0.45) NR1H3NR1H2NPC1RAB9A
SCHEMBL17640393 0.88 SMN1; SMN2 (0.49) NR1H3NR1H2NPC1RAB9AALDH1A1
SCHEMBL17640491 0.86 SMN1; SMN2 (0.48) NR1H3NR1H2NPC1RAB9AALDH1A1
SCHEMBL17640391 0.86 SMN1; SMN2 (0.48) NR1H3NR1H2NPC1RAB9AALDH1A1
SCHEMBL17640503 0.86 SMN1; SMN2 (0.48) NR1H3NR1H2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency UDC IRELAND LIMITED (IE) 2019-06-25 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency BASF SE (DE) 2017-10-26 — — US disclosed
WO-2016046350-A1 FLUORESCENT ORGANIC LIGHT EMITTING ELEMENTS HAVING HIGH EFFICIENCY BASF SE (DE) 2016-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10333078-B2 Fluorescent organic light emitting elements having high efficiency NR2E3, CRY1, ALDH1A2 NR1H3 1274/4885NR1H2 1878/4885NPC1 4857/4885
US-20170309828-A1 Fluorescent Organic Light Emitting Elements Having High Efficiency NR2E3, CRY1, ALDH1A2 NR1H3 1274/4885NR1H2 1878/4885NPC1 4857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback